NICOLE ROSENDO: Open Payments
NPI 1144714395 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 18 payments from 5 companies in 2025. Trend: 2023 $794 · 2024 $807 · 2025 $291
Food & beverage: $257Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $143 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $55 |
| BioCryst US Sales Co., LLC | 1 | $37 |
| Amgen Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: NUCALA, NEFFY, TRELEGY ELLIPTA, ORLADEYO, Rhapsido.
Industry payments across CA — which companies pay providers there.
